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Background: Quality of life in patients affected with chronic diseases has developed into a therapeutic objective
as the best tool to evaluate response to treatment and medical care. The purpose of this study was to evaluate
quality of life and its related factors in tuberculosis patients receiving directly observed treatment short-course in
Iran.
Methods: This was a cross-sectional research with a descriptive-analytic design. Sample size included 71 patients
affected with tuberculosis based on census method; so that, at the time of the study, all the tuberculosis patients
were recruited in this research. The data collection instrument was a questionnaire comprised of two parts
including demographic characteristics information and standard 36-Item Short Form Health Survey (SF-36). The
data were also analyzed using SPSS Statistics along with descriptive and analytic statistics and independent t-
tests, analysis of variance (ANOVA), and Chi-square test.
Results: The lowest mean score was 63.58 ± 10.16 and 62.82 ± 15.2 related to limited physical activity
following mental problems and social functioning, respectively. Furthermore, the findings of the independent t-
test demonstrated that the mean scores of quality of life among men and women, those with pulmonic and non-
pulmonic tuberculosis, patient's place of residence and the stage of treatment were statistically and significantly
different.
Conclusion: According to the above results, tuberculosis and its treatment have impact on the social function,
mental, and emotional aspects of the quality of life of patients, Attention to and monitoring of the quality of life
as a follow up of the treatment and care intervention in these patients is necessary.
1. Introduction
There is an ever-increasing interest in evaluating and improving
quality of life among patients with chronic diseases. As a result, im-
proved daily functioning and quality of life (QOL)1 in such individuals
has turned into a therapeutic objective [1]. Additionally, health care
providers have realized that considering the physical aspects of the
disease alone is not suffice by itself and that the best and the most
effective treatments should be advocated to help patients achieve a
normal life, with QOL being considered as one of the variables [2].
Moreover, results of clinical trials have shown that QOL can be used as
an indicator of the quality of health care services and a part of the
treatment plan for patients such that its evaluation in the domain of
chronic diseases can provide of heath care providers with more in-
formation about patients’ health status and serve as a useful guide to
improve the quality of treatment and care services [3]. Today, QOL is
increasingly used to evaluate patient care outcomes rather than tradi-
tional criteria such as mortality and illness [3]. Studies have shown that
quality of life in chronic diseases is associated with a lot of changes;
therefore, in most patients with chronic disease, many aspects of quality
of life are disturbed [4].
In this respect, tuberculosis is considered as one of the illnesses that
can seriously undermine QOL [5]. The factors that have been cited as
most important in influencing QOL in patients affected with TB, have
been long-term treatment; multi-drug therapy; toxic reactions and side
effects of medications; adherence to drug regimen; social impacts; so-
cial support; social acceptance of the illness; family; changes in lifestyle;
patients’ marital status; extent of access to health care services; socio-
economic status; patients’ and their family's knowledge of the illness,
treatments; as well as complications of tuberculosis [6-8]. Currently,
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tuberculosis management strategy is based on preventing mortality and
avoiding morbidity. Quality of life monitoring is the best method for
achieving this goal [9].
Tools with the potential to evaluate health status in all dimensions
have become of great interest in epidemiological studies [10]. In this
respect, the standard 36-Item Short Form Health Survey (SF-36)2 has
proven effective in clinical applications, evaluation of health research
policies, and population-based studies as it is not related to specific age
groups, communities, and diseases but evaluates two dimensions of a
person's physical and mental health status [11,12]. This questionnaire
also considers health status related to QOL, including multiple dimen-
sions (physical, mental, and social) and has emerged as a useful tool in
reporting the outcomes of therapeutic and care-related indicators [13].
Assessing QOL is a good response and an effective factor in ex-
pressing the level and outcome of health [11]. In patients with pul-
monary diseases, this survey questionnaire has been shown to be a good
tool for evaluating response to treatment and proper physiological
functioning of the respiratory tract [14].
Since maximizing QOL is one of the main goals of tuberculosis
treatment and care, health care providers and researchers need more
information, as the first step, about QOL, its related factors, and how to
promote it. Therefore, the purpose of this study was to evaluate QOL
and related factors in patients receiving directly observed treatment
short-course (DOTS).
2. Research method
The present study was a cross-sectional study with a descriptive-
analytic design, approved by the Ethics Committee affiliated with the
Shahrekord University of Medical Sciences (IR.SKUMS.REC.716). Study
subjects included all patients with tuberculosis undergoing DOTS
treatment (70 persons) at the time of the study,. All of the patients were
from a province with mountainous weather and unsuitable economic
conditions. In Iran, healthcare is managed by the health authorities of
each province and is independent of other provinces.
The data collection instrument was a questionnaire consisting of
two parts including demographic characteristics, medications used,
duration of treatment, type of tuberculosis (pulmonary and extra-pul-
monary), and illness case (new or recurrence) and Quality of Life
Questionnaire(SF- 36). This questionnaire has 36 question that were
designed by War and et al. in 1991 and measures QOL in 8 dimensions:
physical function, limited physical activity following mental problems,
limited physical activity following physical problems, vitality and fa-
tigue, mental health, social functioning, bodily pain, and general
health. The QOL score in each dimension is graded from 0–100, with 0
indicating the lowest QOL and 100 indicating the highest quality of life
[15]. In another classification, grades from 0 to 49 are classified as
undesirable, 50–74 as relatively favorable, 75 and above as desirable
[16]. After registering the patients’ complete profile from their medical
records in the Tuberculosis Center of Chaharmahal and Bakhtiari Pro-
vince, the researchers visited patients at their homes with the full co-
ordination of the relevant Health Center and completed the demo-
graphic characteristics questionnaire, the SF-36 questionnaire, and
other required information. The data were analyzed using SPSS Sta-
tistics along with descriptive and inferential statistical tests via in-
dependent t-test, ANOVA, and Chi-square test.
3. Results
Form the total number of 71 patients who entered the study, 53.1%
were male and 46.9% were female, 89.1% had Iranian nationality, and
10.9% of them were foreigners. In terms of place of residence, 76.6% of
the patients were living in urban areas and 23.4% of them resided in
rural ones. As regards their tuberculosis diagnosis 60.9% of these in-
dividuals were suffering from pulmonary tuberculosis and 39.1% of
them were affected with extra pulmonary tuberculosis. In addition,
93.2% of the patients were diagnosed as new cases and 6.8% of them
were classified as recurrent tuberculosis cases.
The mean standard deviation (SD) of age of the patients was
51.11 ± 21.25 years and the mean duration of treatment was
7.47 ± 2.37 months. The mean scores for 8 dimensions of quality of
life in patients are illustrated in Table 1. The results of the ANOVA
analysis showed a significant relationship between the duration of
treatment and the total QOL score; patients experiencing their third
trimester of treatment had lower mean scores. Women, patients who
live in urban areas and patients with extra pulmonary tuberculosis had
a significantly higher mean QOL scores than men, patients living in
rural areas and patients with pulmonary tuberculosis (Table 2).
4. Discussion
Compared to the results of the study, khoohi et al., The average
quality of life of the majority of people in some countries was 74.26
[17], therefore the results of the present study indicate that the mean
QOL scores among tuberculosis patients undergoing DOTS in Cha-
harmahal and Bakhtiari Province were much lower than the normal
range. Furthermore, patients who were in the last stage of treatment
had a lower mean QOL score as had men, patients living in rural areas
and patients with pulmonary tuberculosis.
Relatively few investigations had been conducted on QOL in tu-
berculosis patients [8]. In the study by Adeyeye et al., the mean QOL
scores in patients with pulmonary tuberculosis were lower than normal
values with regard to factors affecting QOL including age, gender,
economic status, unemployment, duration of treatment, and accom-
panying diseases [18]. These findings, even though the study was car-
ried out in a different cultural background, are similar findings in the
present study. In the study by Jastrzebski et al., mean QOL scores were
low in patients with lung involvement including pulmonary fibrosis,
chronic obstructive pulmonary disease, or tuberculosis. Moreover, the
mean QOL scores in tuberculosis patients were much lower than those
suffering from other chronic pulmonary diseases [14]. The study by
Guryleva and Gerasimova evaluating and comparing QOL in 29 TB
patients to QOL in 20 healthy individuals concluded that QOL in TB
patients was impaired in the 3 dimensions of physical function, physical
status, and emotional condition, with a larger impact noted in patients
whose course of treatment was completed. Thus, it has been argued that
tuberculosis as a chronic infectious disease could undermine QOL
during and after treatment; indicating that monitoring QOL with the
right tools could be part of the follow-up of treatment and care for these
patients [19]. In the present study, the dimensions of emotional and
social functioning had the lowest mean scores, underscoring the im-
portance of emotional and social functioning in these patients since TB
was a transferable disease and people in communities tend to com-
municate less with infected individuals as manifested in their social
situations.
In the study by Marra et al., QOL was evaluated using the SF-36
questionnaire in two groups of patients: Patients with active tubercu-
losis (110 individuals) and patients with latent TB (100 individuals).
The mean QOL scores in patients with active TB were significantly
greater than those with latent TB in the majority of QOL dimensions.
Similar to our study, QOL in patients decreased over the course of
treatment. In the study by Ramkumar et al., although the mean QOL
scores in TB patients were as low, DOTS appeared to improve QOL
scores almost to the level of the general population [20].
Chama and colleagues compared QOL in 102 TB patients via DOTS
with 103 healthy individuals using the SF-36 questionnaire. The results
revealed that QOL in TB patients was lower than in the general popu-
lation in all dimensions, especially social functioning, physical function,
and mental health,. Furthermore, patients with more clinical symptoms,2 Short form
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leukocytosis, and older age had lower QOL mean scores. Similar to the
findings by Ramkumar et al., mean QOL scores in TB patients increased
during the third and the sixth months of treatment [21]. The increase in
QOL scores in the course of treatment in these 2 studies differs from
findings from the present study, but was an important finding.
Dhingra et al. conducted a study at the Tuberculosis Center in New
Delhi, India on 75 patients with pulmonary and extra-pulmonary tu-
berculosis receiving DOTS in which QOL was evaluated at the begin-
ning and at the end of treatment using Health-Related Quality of Life
Questionnaire (HRQLQ). At the beginning of treatment, there was no
statistically significant difference in mean QOL scores between patients
with pulmonary vs. extra-pulmonary tuberculosis, although their mean
QOL scores were lower than those in healthy individuals. At the end of
treatment, the mean QOL scores in patients with pulmonary tubercu-
losis were significantly higher than in patients with extra-pulmonary
tuberculosis [22]. These findings are in contrast to findings from the
present study.
In the present study, the mean QOL scores in rural patients were
lower than those living in urban areas possibly due to a low level of
knowledge, lower economic status, and inadequate level of nutrition
Carroll and colleagues at the Tuberculosis Research Center in
Vancouver evaluated QOL in 84 TB patients; 62% were male and 38%
female. The mean age was 46.2 years, 28% of the patients were re-
ported co infected with HIV, 18% hadhepatitis B, 23% of them were
diagnosed with alcohol use disorder, and 34% had no full-time jobs,.
The mean QOL scores in patients living in rural areas, those with ac-
companying diseases especially HIV/AIDS and hepatitis, individuals
deprived of family and social support, and patients with insufficient
knowledge of their disease were lower than other individuals in their
groups [23]. Therefore, it was concluded that Accordingly, health care
providers as well as medical and health care giver were required to pay
much more attention to QOL in patients as a monitoring tool evaluating
medical care and treatment respond along with prescribing medica-
tions.
5. Conclusion
Various factors threaten QOL of patients with tuberculosis in the
course of infection, during and after treatment. Monitoring quality of
life should be part of the evaluation of response to long term treatment
and medical care for patients with tuberculosis. A negative impact on
various domain of quality of life, including social and mental domains,
during the long-term treatment of tuberculosis has been noted. Paying
attention to quality of life in the care of patients could help minimize
this damage and facilitate the return of patients to their communities.
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